{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:17:21Z","timestamp":1780089441936,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T00:00:00Z","timestamp":1416873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2415-14-144","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T02:01:32Z","timestamp":1416880892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Overexpression p21WAF1\/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E"],"prefix":"10.1186","volume":"14","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,25]]},"reference":[{"key":"504_CR1","first-page":"1325","volume":"6","author":"A Sadaka","year":"2012","unstructured":"Sadaka A, Giuliari GP: Proliferative vitreoretinopathy: current and emerging treatments. Clin ophtalmol. 2012, 6: 1325-1333.","journal-title":"Clin ophtalmol"},{"key":"504_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/IAE.0b013e31826b0c41","volume":"33","author":"MA Cunningham","year":"2013","unstructured":"Cunningham MA, Tarantola RM, Folk JC, Sohn EH, Boldt HC, Graff JA, Elkins K, Russell SR, Mahajan VB: Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases. Retina. 2013, 33: 579-585. 10.1097\/IAE.0b013e31826b0c41.","journal-title":"Retina"},{"key":"504_CR3","first-page":"355","volume":"17","author":"T Fillies","year":"2007","unstructured":"Fillies T, Woltering M, Brandt B, Van Diest JP, Werkmeister R, Joos U, Buerger H: Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas. Oncol Rep. 2007, 17: 355-359.","journal-title":"Oncol Rep"},{"key":"504_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1517\/13543784.12.6.955","volume":"12","author":"PM Fischer","year":"2003","unstructured":"Fischer PM, Gianella-Borradori A: CDK inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs. 2003, 12: 955-970. 10.1517\/13543784.12.6.955.","journal-title":"Expert Opin Investig Drugs"},{"key":"504_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1091\/mbc.6.4.387","volume":"6","author":"JW Harper","year":"1995","unstructured":"Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E: Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell. 1995, 6: 387-400. 10.1091\/mbc.6.4.387.","journal-title":"Mol Biol Cell"},{"key":"504_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1078\/0065-1281-00584","volume":"103","author":"Y Ueda","year":"2001","unstructured":"Ueda Y, Kanazawa S, Kitaoka T, Dake Y, Ohira A, Ouertani AM, Amemiya T: Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem. 2001, 103: 159-165. 10.1078\/0065-1281-00584.","journal-title":"Acta Histochem"},{"key":"504_CR7","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1167\/iovs.02-1198","volume":"44","author":"I Audo","year":"2003","unstructured":"Audo I, Darjatmoko SR, Schlamp CL, Lokken JM, Lindstrom MJ, Albert DM, Nickells RW: Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci. 2003, 44: 4192-4199. 10.1167\/iovs.02-1198.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"504_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/sj.gt.3302253","volume":"11","author":"G Heatley","year":"2004","unstructured":"Heatley G, Kiland J, Faha B, Seeman J, Schlamp CL, Dawson DG, Gleiser J, Maneval D, Kaufman PL, Nickells RW: Gene therapy using p21WAF-1\/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension. Gene Ther. 2004, 11: 949-955. 10.1038\/sj.gt.3302253.","journal-title":"Gene Ther"},{"key":"504_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1535-6108(03)00308-8","volume":"4","author":"RH Weiss","year":"2003","unstructured":"Weiss RH: P21Waf1\/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell. 2003, 4: 425-429. 10.1016\/S1535-6108(03)00308-8.","journal-title":"Cancer Cell"},{"key":"504_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biopha.2011.02.009","volume":"65","author":"YF Zhao","year":"2011","unstructured":"Zhao YF, Wang CR, Wu YM, Ma SL, Ji Y, Lu YJ: P21 (waf1\/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment. Biomed Pharmacother. 2011, 65: 151-156. 10.1016\/j.biopha.2011.02.009.","journal-title":"Biomed Pharmacother"},{"key":"504_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0002-9394(14)77370-2","volume":"93","author":"DM Fastenberg","year":"1982","unstructured":"Fastenberg DM, Diddie KR, Dorey K, Ryan SJ: The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am J Ophthalmol. 1982, 93: 565-572. 10.1016\/S0002-9394(14)77370-2.","journal-title":"Am J Ophthalmol"},{"key":"504_CR12","volume-title":"J Fr Ophtalmol","author":"C Chiquet","year":"2014","unstructured":"Chiquet C, Rouberol F: Proliferative vitreoretinopathy: pathophysiology and clinical diagnosis. J Fr Ophtalmol. 2014, Epub ahead of print"},{"key":"504_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1096\/fj.13-229740","volume":"28","author":"K1 Ishikawa","year":"2014","unstructured":"Ishikawa K1, Yoshida S, Nakao S, Nakama T, Kita T, Asato R, Sassa Y, Arita R, Miyazaki M, Enaida H, Oshima Y, Murakami N, Niiro H, Ono J, Matsuda A, Goto Y, Akashi K, Izuhara K, Kudo A, Kono T, Hafezi-Moghadam A, Ishibashi T: Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J. 2014, 28: 131-142. 10.1096\/fj.13-229740.","journal-title":"FASEB J"},{"key":"504_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000320496","volume":"45","author":"ML Lin","year":"2011","unstructured":"Lin ML, Li YP, Li ZR, Lin JX, Zhou XL, Liang D: Macrophages acquire fibroblast characteristics in a rat model of proliferative vitreoretinopathy. Ophthamic Res. 2011, 45: 180-190. 10.1159\/000320496.","journal-title":"Ophthamic Res"},{"key":"504_CR15","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1167\/iovs.06-0198","volume":"48","author":"R Ganti","year":"2007","unstructured":"Ganti R, Hunt RC, Parapuram SK, Hunt DM: Vitreous modulation of gene expression in low-passage human retinal pigment epithelial cells. Invest Ophthalmol Vis Sic. 2007, 48: 1853-1863. 10.1167\/iovs.06-0198.","journal-title":"Invest Ophthalmol Vis Sic"},{"key":"504_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/onc.2008.358","volume":"28","author":"I Neganova","year":"2009","unstructured":"Neganova I, Zhang X, Atkinson S, Lako M: Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene. 2009, 28: 20-30. 10.1038\/onc.2008.358.","journal-title":"Oncogene"},{"key":"504_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mrrev.2010.01.009","volume":"704","author":"O Cazzalini","year":"2010","unstructured":"Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E: Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res. 2010, 704: 12-20. 10.1016\/j.mrrev.2010.01.009.","journal-title":"Mutat Res"},{"key":"504_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF01007739","volume":"17","author":"M Velikay","year":"1993","unstructured":"Velikay M, Stolba U, Wedrich A, Datlinger P, Binder S, Handl-Zeller L: Irradiation pretreatment before fibroblast implantation in experimental PVR. Int Opthalmol. 1993, 17: 191-193. 10.1007\/BF01007739.","journal-title":"Int Opthalmol"},{"key":"504_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF00184007","volume":"232","author":"S Binder","year":"1994","unstructured":"Binder S, Bonnet M, Velikay M, Gerard JP, Stolba U, Wedrich A, Hohenberg H: Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study. Graefes Arch Clin Exp Opthalmol. 1994, 232: 211-214. 10.1007\/BF00184007.","journal-title":"Graefes Arch Clin Exp Opthalmol"},{"key":"504_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4161\/cc.4.5.1672","volume":"4","author":"AR Nair","year":"2005","unstructured":"Nair AR, Schliekelman M, Thomas MB, Wakefield J, Jurgensen S, Ramabhadran R: Inhibition of p53 by lentiviral mediated shRNA abrogates G1 arrest and apoptosis in retinal pigmented epithelial cell line. Cell Cycle. 2005, 4: 697-703. 10.4161\/cc.4.5.1672.","journal-title":"Cell Cycle"},{"key":"504_CR21","doi-asserted-by":"publisher","first-page":"19078","DOI":"10.1371\/journal.pone.0019078","volume":"6","author":"SM Cashman","year":"2011","unstructured":"Cashman SM, Ramo K, Kumar-Singh R: A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration. PLoS One. 2011, 6: 19078-10.1371\/journal.pone.0019078.","journal-title":"PLoS One"},{"key":"504_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3109\/02713683.2012.746992","volume":"38","author":"J Han","year":"2013","unstructured":"Han J, Yuan Z, Yan H: Inhibitory effect of adenoviral vector-mediated delivery of p21WAF1\/CIP1 on retinal vascular endothelial cell proliferation and tube formation in cultured Rhesus monkey cells (RF\/6A). Curr Eye Res. 2013, 38: 670-673. 10.3109\/02713683.2012.746992.","journal-title":"Curr Eye Res"},{"key":"504_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.neuroscience.2013.07.001","volume":"250","author":"F Meng","year":"2013","unstructured":"Meng F, Wang X, Gu P, Wang Z, Guo W: Induction of retinal ganglion-like cells from fibroblasts by adenoviral gene delivery. Neuroscience. 2013, 250: 381-393.","journal-title":"Neuroscience"},{"key":"504_CR24","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.joms.2008.06.079","volume":"67","author":"S Zhang","year":"2009","unstructured":"Zhang S, Li Y, Li L, Zhang Y, Gao N, Zhang Z, Zhao H: Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia. J Oral Maxillofac Surg. 2009, 67: 1074-1082. 10.1016\/j.joms.2008.06.079.","journal-title":"J Oral Maxillofac Surg"},{"key":"504_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10517-010-0873-8","volume":"149","author":"NV Ryazantseva","year":"2010","unstructured":"Ryazantseva NV, Novitskii VV, Zhukova OB, Biktasova AK, Chechina OE, Sazonova EV, Radzivil TT, Wice AN, Chasovskikh NY: Role of NF-kB, p53, and p21 in the regulation of TNF-\u03b1 mediated apoptosis of lymphocytes. Bull Exp Biol Med. 2010, 149: 50-53. 10.1007\/s10517-010-0873-8.","journal-title":"Bull Exp Biol Med"},{"key":"504_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10059-010-0131-y","volume":"30","author":"JH Lee","year":"2010","unstructured":"Lee JH, Lee SY, Lee JH, Lee SH: P21 WAF1 is involved in interferon-\u03b2-induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression in ovarian cancer. Mol Cells. 2010, 30: 327-333. 10.1007\/s10059-010-0131-y.","journal-title":"Mol Cells"},{"key":"504_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000077577","volume":"41","author":"WH Stotz","year":"2004","unstructured":"Stotz WH, Li D, Johns RA: Exogenous nitric oxide upregulates p21(waf1\/cip1) in pulmonary microvascular smooth muscle cells. J Vasc Res. 2004, 41: 211-219. 10.1159\/000077577.","journal-title":"J Vasc Res"},{"key":"504_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.surg.2005.03.023","volume":"138","author":"W Stehr","year":"2005","unstructured":"Stehr W, Mercer TI, Bernal NP, Erwin CR, Warner BW: Opposing roles for p21(waf1\/cip1) and p27(kip1) in enterocyte differentiation, proliferation, and migration. Surgery. 2005, 138: 187-194. 10.1016\/j.surg.2005.03.023.","journal-title":"Surgery"},{"key":"504_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s13402-011-0044-6","volume":"34","author":"I Chatzistamou","year":"2011","unstructured":"Chatzistamou I, Dioufa N, Trimis G, Sklavounou A, Kittas C, Kiaris H, Papavassiliou AG: P21\/waf1 and smooth-muscle actin alpha expression in stromal fibroblasts of oral cancers. Cell Oncol. 2011, 34: 483-488. 10.1007\/s13402-011-0044-6.","journal-title":"Cell Oncol"},{"key":"504_CR30","first-page":"529","volume":"27","author":"JJ Wang","year":"2012","unstructured":"Wang JJ, Hung HF, Huang ML, Lee HJ, Chern YT, Chang YF, Chi CW, Hsu YC: Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells. Oncol Rep. 2012, 27: 529-534.","journal-title":"Oncol Rep"},{"key":"504_CR31","doi-asserted-by":"publisher","first-page":"56819","DOI":"10.1371\/journal.pone.0056819","volume":"8","author":"CM Chan","year":"2013","unstructured":"Chan CM, Chang HH, Wang VC, Huang CL, Hung CF: Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFR\u03b2, PI3K\/Akt and MAPK pathways. Plos One. 2013, 8: 56819-10.1371\/journal.pone.0056819.","journal-title":"Plos One"},{"key":"504_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2741\/S398","volume":"1","author":"L Zhang","year":"2013","unstructured":"Zhang L, Wang F, Jiang Y, Xu S, Lu F, Wang W, Sun X, Sun X: Migration of retinal pigment epithelial cells is EGFR\/PI3K\/AKT dependent. Front Biosc. 2013, 1: 661-671.","journal-title":"Front Biosc"},{"key":"504_CR33","first-page":"1031","volume":"28","author":"G P\u00e9rez-Tenorio","year":"2006","unstructured":"P\u00e9rez-Tenorio G, Berglund F, Esguerra Merca A, Nordenskj\u00f6ld B, Rutqvist LE, Skoog L, St\u00e5l O: Cytoplasmic p21WAF1\/CIP1 correlates with Akt activation and poor response to tamoxifen in breast cancer. Int J Oncol. 2006, 28: 1031-1042.","journal-title":"Int J Oncol"},{"key":"504_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nprot.2007.4","volume":"2","author":"RN Agrawal","year":"2007","unstructured":"Agrawal RN, He S, Spee C, Cui JZ, Ryan SJ, Hinton DR: In vivo models of proliferative vitreoretinopathy. Nat Protoc. 2007, 2: 67-77. 10.1038\/nprot.2007.4.","journal-title":"Nat Protoc"},{"key":"504_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1368-7646(03)00044-X","volume":"6","author":"S Liu","year":"2003","unstructured":"Liu S, Bishop WR, Liu M: Differential effectsof cellcycle regulatory protein p21(WAF1\/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat. 2003, 6: 183-195. 10.1016\/S1368-7646(03)00044-X.","journal-title":"Drug Resist Updat"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-14-144\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:53:13Z","timestamp":1630565593000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-14-144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-14-144","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,25]]},"assertion":[{"value":"13 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"144"}}